Search Web Site
Personal tools
Log in

Forgot your password?
You are here: Home About SCATLA


Sudden cardiac arrest (SCA) is the leading cause of death in the United States, killing up to 350,000 people annually. Treatment and the quality of care designed to prevent SCA remain inconsistent. Many patients, particularly racial minorities and women, are not receiving evidence-based therapies that have been shown to prevent SCA.

The Sudden Cardiac Arrest Thought Leadership Alliance (SCATLA) was formed to improve the quality of care around SCA and to share and develop educational tools for patients and healthcare providers. SCATLA is committed to helping providers better identify patients at risk for SCA and reduce disparities that exist so that care can continue to improve.

SCATLA comprises experts from clinical cardiology, cardiac electrophysiology, and health policy and economics. It is led by Duke University. SCATLA has conducted two think tank meetings attended by members of the U.S. Food and Drug Administration, the Centers for Medicare and Medicaid Services, the Agency for Health Care Research and Quality, and device and pharmaceutical manufacturers, in addition to the members of the Alliance.


SCATLA directors and participants



Addressing disparities in sudden cardiac arrest care and the under-utilization of effective therapies

Systematic review of the incidence of sudden cardiac death in the United States

Performance measures to promote quality improvement in sudden cardiac arrest prevention and treatment

Assessment of the quality of existing patient education tools focused on sudden cardiac arrest: a systematic evaluation by the Sudden Cardiac Arrest Thought Leadership Alliance

Quality of care for sudden cardiac arrest: proposed steps to improve the translation of evidence into practice


Document Actions